Frova (Frovatriptan)
Medication information written by Dr. Larisa Roybal, PharmD
Updated - April 3, 2021
Frova (Frovatriptan) Medication Information
Uses
Frova is a serotonin receptor agonist that is used to treat migraines with and without aura.
Dosage
The tablets are available in 2.5 mg strength.
Side Effects
The most common side effects of Frova include:
- Dizziness
- Fatigue
- Headache
- Dry mouth
- Dyspepsia
- Chest pain
- Flushing
Speak with your doctor for a full list of side effects that apply to you if you are taking Frovatriptan .
Precautions
There is a risk of heart attack and angina, as well as heart arrhythmia with Frovatriptan use.
There is a risk of stroke and hemorrhage with Frovas use, if these occur Frova should be stopped.
In cases of overuse of Frovatriptan , there is a risk of overuse headache.
Interactions
The most common drug interactions with Frova include:
- Ergot containing drugs
- SSRIs
- SNRIs
- TCAs
- MAOIs
- Triptans
Speak with your doctor for more information and before starting a new medication with Frovatriptan.
Storage
Store at room temperature (59-86 ºF). Protect from moisture.
Pharmacist Tips
- Frova can cause serotonin syndrome.
- Frova should be taken with fluid.
- You can take a second Frova dose 2 hours after the first if there is not enough relief.
Frovatriptan FAQs
How many Frova can you take in 24 hours?
Do not take more than 3 tablets in 24 hours.
What are common side effects of Frova?
The most common side effects seen with Frovatriptan are dizziness, headache, dry mouth, fatigue, chest pain, and flushing.
How long does it take for Frova to work?
You should experience relief within 2 hours of taking Frova, if not you can take another tablet.
How long does Frova stay in your system?
Frova stays in the system much longer than other triptans, typically it is in the body for up to 7 days.
Does Frova make you sleepy?
One of the side effects of Frovatriptan is fatigue.
Related Drugs
Reference:
Frova {package insert}. Malvern, PA: Endo Pharmaceuticals Inc.; 2013.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021006s019lbl.pdf

Author: Dr. Larisa Roybal, PharmD
Dr. Roybal is a board-certified pharmacotherapy specialist who has practiced in both ambulatory and acute care settings. Her pharmacy interests include oncology and general inpatient pharmacy.

